{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T18:17:42Z","timestamp":1761934662708,"version":"build-2065373602"},"reference-count":43,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T00:00:00Z","timestamp":1326672000000},"content-version":"vor","delay-in-days":2693,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:p><jats:bold>Study Objectives.<\/jats:bold> To assess gastric pH measurements, evaluate the frequency of guaiac\u2010positive gastric aspirates, and characterize the appearance of gastric aspirates in neonates receiving acid suppression therapy during extracorporeal membrane oxygenation (ECMO).<\/jats:p><jats:p><jats:bold>Design.<\/jats:bold> Retrospective, observational study.<\/jats:p><jats:p><jats:bold>Setting.<\/jats:bold> Intensive care unit in a 225\u2010bed tertiary care pediatric referral hospital.<\/jats:p><jats:p><jats:bold>Subjects.<\/jats:bold> Thirteen neonates receiving ECMO.<\/jats:p><jats:p><jats:bold>Measurements and Main Results.<\/jats:bold> Gastric pH measurements, guaiac test results, appearance of gastric aspirates, and ranitidine and antacid dosing were recorded. On ECMO day 1, mean \u00b1 SD gastric pH was 4.3 \u00b1 2.8 in the five neonates whose pH was documented. Intravenous ranitidine 2.9 \u00b1 0.4 mg\/kg\/day was started in all neonates by ECMO day 2. Gastric pH was less than 4.0 in seven neonates; these low pH values accounted for only 10% of gastric pH measurements. The frequency of positive guaiac results in neonates with pH measurements below 4.0 was 27% compared with 41% for neonates with a gastric pH of 4.0 or greater (p=0.125). Guaiac tests were positive in 69 (42%) aspirates in 11 neonates. Of the guaiac\u2010positive aspirates that had a corresponding pH measurement, 94% had a pH of 4.0 or greater. Guaiac\u2010positive aspirates had evidence of bile (49%), antacid (17%), and blood (7%) in gastric fluid. In six patients, ranitidine dosages were increased to 3.9 \u00b1 0.6 mg\/kg\/day due to low pH and\/or positive guaiac results. In two of these neonates, gastric pH remained below 4.0 in nine of 35 pH measurements despite increased ranitidine dosing. Guaiac results remained positive in all subsequent aspirates in five out of six of these neonates. No neonates developed clinically significant upper gastrointestinal bleeding (UGIB).<\/jats:p><jats:p><jats:bold>Conclusions.<\/jats:bold> Gastric pH is variable in neonates receiving histamine<jats:sub>2<\/jats:sub>\u2010receptor antagonist and antacid therapy during ECMO, and gastric pH of 4.0 or greater does not decrease the frequency of guaiac\u2010positive aspirates. Higher gastric pH measurements are confounded by duodenogastric reflux and the presence of blood and\/or antacid in gastric fluid. Motility agents in combination with acid suppression therapy for prevention of UGIB may be necessary in this setting based on gastric pH measurements, appearance of gastric aspirates, and guaiac testing.<\/jats:p>","DOI":"10.1592\/phco.24.13.1130.38085","type":"journal-article","created":{"date-parts":[[2004,8,11]],"date-time":"2004-08-11T10:09:29Z","timestamp":1092218969000},"page":"1130-1136","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of Gastric pH and Guaiac Measurements in Neonates Receiving Acid Suppression Therapy During Extracorporeal Membrane Oxygenation"],"prefix":"10.1002","volume":"24","author":[{"given":"Catherine M.","family":"Crill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.","family":"Bugnitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily B.","family":"Hak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,16]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.4.933"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199211000-00007"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199201000-00013"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199208000-00003"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001340051346"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0022-5223(94)70340-X","article-title":"Complications of neonatal extracorporeal membrane oxygenation","volume":"107","author":"Zwischenberger JB","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"volume-title":"Extracorporeal life support (ECLS) registry report. International summary","year":"2003","author":"Extracorporeal Life Support Organization.","key":"e_1_2_1_8_2"},{"key":"e_1_2_1_9_2","first-page":"1143","article-title":"Abnormal regulation of vitamin D\u2010endocrine system in neonatal extracorporeal membrane oxygenation therapy [abstr]","volume":"18","author":"Hak EB","year":"1998","journal-title":"Pharmacotherapy"},{"key":"e_1_2_1_10_2","first-page":"740","volume-title":"Textbook of medical physiology","author":"Guyton AC","year":"2000"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-003-1259-y"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1536-4801.2003.tb08002.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.81.1.16"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3468(05)80332-X"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3468(91)90848-N"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1536-4801.1991.tb10269.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1536-4801.1990.tb10006.x"},{"key":"e_1_2_1_18_2","first-page":"447","article-title":"Duodenogastric reflux and reflux esophagitis","volume":"96","author":"Little AG","year":"1984","journal-title":"Surgery"},{"key":"e_1_2_1_19_2","first-page":"525","article-title":"Role of bile salts and trypsin in the pathogenesis of experimental alkaline esophagitis","volume":"93","author":"Salo JA","year":"1983","journal-title":"Surgery"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01307977"},{"issue":"67","key":"e_1_2_1_21_2","first-page":"119","article-title":"Effect of bile salts and related compounds on esophageal mucosa","volume":"16","author":"Kivilaakso E.","year":"1981","journal-title":"Scand J Gastroenterol"},{"issue":"67","key":"e_1_2_1_22_2","first-page":"99","article-title":"Bile acid\u2010induced acute gastric mucosal damage: a useful experimental model","volume":"16","author":"Ritchie WP.","year":"1981","journal-title":"Scan J Gastroenterol"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.2.434"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70069-0"},{"key":"e_1_2_1_25_2","first-page":"G1046","article-title":"Enteral nutrients promote postnatal maturation of intestinal motor activity in preterm infants","volume":"264","author":"Berseth CL","year":"1993","journal-title":"Am J Physiol"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)81969-9"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1139\/y85-092"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0095-5108(18)30237-9"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.90.5.669"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1053\/jpsu.2001.27027"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199802000-00041"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3468(98)90355-4"},{"key":"e_1_2_1_33_2","first-page":"G469","article-title":"Erythromycin is a motilin receptor agonist","volume":"257","author":"Peeters T.","year":"1989","journal-title":"Am J Physiol"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)91089-Z"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200207000-00005"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1536-4801.2003.tb12061.x"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.117577"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199808000-00032"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1998.tb04443.x"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80052-6"},{"key":"e_1_2_1_41_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2036.1990.tb00010.x","article-title":"Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine","volume":"4","author":"Nwokolo CU","year":"1990","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_1_42_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2036.1990.tb00009.x","article-title":"Loss of acid suppression during dosing with H2\u2010receptor antagonists","volume":"4","author":"Wilder\u2010Smith C.","year":"1990","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(87)80027-6"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1536-4801.1985.tb08844.x"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.24.13.1130.38085","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.24.13.1130.38085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:39:52Z","timestamp":1761053992000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.24.13.1130.38085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1592\/phco.24.13.1130.38085"],"URL":"https:\/\/doi.org\/10.1592\/phco.24.13.1130.38085","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"2012-01-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}